Clinical Trials in Ohio

Showing 6721-6740 of 20,938 trials

Active Not RecruitingNA32 miles

Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair

NCT05142618

This study aims to evaluate the potential role of physical therapy in improving outcomes after ventral hernia repair.

Ventral HerniaHerniaHerniorrhaphy+3 more

Ohio State University138 participantsStarted Apr 2022

Columbus, Ohio, United States

Enrolling By InvitationPhase 232 miles

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT06547216

A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

FSHDFSHD1FSHD2+24 more

Avidity Biosciences, Inc.84 participantsStarted Jul 2024

Los Angeles, California, United States • Palo Alto, California, United States • San Diego, California, United States +14 more locations

Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

Find Trials by Condition in Ohio

A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

InterStim Micro Post Market Clinical Follow-up Study (ELITE)

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication

CYPRESS Efficacy and Safety Study Extension

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)

Opioid-Free Anesthetic for Tonsillectomy

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Oral ONC201 in Adult Recurrent Glioblastoma

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Global Fenestrated Anaconda Clinical STudy